CVRx (CVRX) 5-Year Yield-on-Cost %: 0.00 (As of Jul. 08, 2026)


CVRX CVRx Inc CVRX
56 GF Score
Price $5.74
GF Value $11.27
Valuation Possible Value Trap
! 4 Warning Signs
View Full Analysis

What is CVRx 5-Year Yield-on-Cost %?

CVRx CVRX +1.95% 56 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus rates CVRX with a GF Score™ of 56/100 and a GF Value™ of $11.27 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 327 Medical Devices & Instruments companies, CVRx ranks worse than 305810.09% on this metric.

CVRx's yield on cost for the quarter that ended in Mar. 2026 was 0.00.


The historical rank and industry rank for CVRx's 5-Year Yield-on-Cost % or its related term are showing as below:



CVRX's 5-Year Yield-on-Cost % is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 2.31
* Ranked among companies with meaningful 5-Year Yield-on-Cost % only.

CVRx  (NAS:CVRX) 5-Year Yield-on-Cost % Explanation

Of course the risk here is that the company may not raise its dividends as it did before. The key is to select the companies that can consistently raise its dividends. Usually companies with long history of raising dividends tend to do so.


CVRx 5-Year Yield-on-Cost % Related Terms


CVRX vs OWLT, HYPR, MXCT: 5-Year Yield-on-Cost % Comparison

For the Medical Devices subindustry, CVRx's 5-Year Yield-on-Cost %, along with its competitors' market caps and 5-Year Yield-on-Cost % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CVRx 5-Year Yield-on-Cost % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, CVRx's 5-Year Yield-on-Cost % distribution charts can be found below:

* The bar in red indicates where CVRx's 5-Year Yield-on-Cost % falls into.


CVRX
56GF Score
CVRx Inc CVRX
5-Year Yield-on-Cost % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

CVRx 5-Year Yield-on-Cost % Calculation

Dividend Yield % and dividend growth of a stock is an important factor for income investors. But if company A raises its dividend constantly faster than company B, company A's future dividend yield might be much higher than Company B's even if their yields are the same now and their stock prices do not change.

Yield on Cost assumes that you buy and the stock today, and hold it for 5 years. If the company raises it dividends at the same rate as it did over the past 5 years, the dividends investors receive annually in 5 years relative to the stock price today.

Therefore, Yield-on-Cost of CVRx is calculated as

Yield-on-Cost=Dividend Yield %*(1+Dividend Growth Rate)^5
Frequently Asked Questions Learn more about 5-Year Yield-on-Cost % →
What does a 5-Year Yield-on-Cost % of 0.00 mean?
CVRx (CVRX) has a 5-Year Yield-on-Cost % of 0.00 as of Jul. 08, 2026. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CVRx and its competitors. According to the industry distribution chart, CVRx ranks #999999 out of 327 companies in the Medical Devices & Instruments industry.
Is CVRx's 5-Year Yield-on-Cost % too high?
CVRx's current 5-Year Yield-on-Cost % is 0.00. Based on the distribution chart, CVRx ranks #999999 out of 327 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, CVRx has a GF Score™ of 56/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does CVRx's 5-Year Yield-on-Cost % compare to OWLT and HYPR?
According to the Medical Devices & Instruments industry distribution chart, CVRx ranks #999999 out of 327 companies for 5-Year Yield-on-Cost %. This places CVRx in the lower half of its industry. The industry median 5-Year Yield-on-Cost % is 2.31. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 5-Year Yield-on-Cost % for a Medical Devices & Instruments company?
The median 5-Year Yield-on-Cost % among Medical Devices & Instruments companies is 2.31, based on 327 companies in the industry. Companies in the top quartile (top 25%) have a 5-Year Yield-on-Cost % significantly above this median, while those in the bottom quartile fall well below. However, 5-Year Yield-on-Cost % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 5-Year Yield-on-Cost % mean?
A high 5-Year Yield-on-Cost % can signal that a stock is expensive relative to its fundamentals. 5-Year Yield on Cost measures the expected yield based on a company's current yield and 5-year dividend growth. View historical data on CVRx and its competitors. For the Medical Devices & Instruments industry, the median 5-Year Yield-on-Cost % is 2.31 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. CVRx's current 5-Year Yield-on-Cost % is 0.00. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is CVRx stock overvalued right now?
Based on GuruFocus' analysis, CVRx (CVRX) is currently considered Possible Value Trap. The stock's GF Value™ is $11.27, compared to a current price of $5.74 — trading 49.1% below its estimated fair value. The current 5-Year Yield-on-Cost % is 0.00. CVRx's overall GF Score™ is 56/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 5-Year Yield-on-Cost % calculated?
5-Year Yield-on-Cost % is calculated from a company's financial statements. For CVRx (CVRX), the current 5-Year Yield-on-Cost % is 0.00 as of Jul. 08, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is CVRx (CVRX) Overvalued in 2026?

Based on GuruFocus' analysis, CVRx stock appears to be undervalued. The current stock price of $5.74 is trading 49.1% below its estimated GF Value™ of $11.27. GuruFocus considers CVRx to be Possible Value Trap.

Key valuation signals for CVRX:

  • 5-Year Yield-on-Cost %: 0.00
  • GF Value™: $11.27 vs. price of $5.74 (49.1% below fair value)
  • GF Score™: 56/100 with 4 warning signs

No single metric tells the full story. See the CVRX stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


CVRx Business Description

Address 9201 West Broadway Avenue, Suite 650, Minneapolis, MN, USA, 55445
CVRx Inc is a commercial-stage medical device company focused on developing, manufacturing, and commercializing minimally invasive neuromodulation solutions for patients with cardiovascular diseases. Its proprietary platform technology, Barostim, is designed to leverage the power of the brain to address the imbalance of the Autonomic Nervous System, which causes heart failure and other cardiovascular diseases. Barostim provides Baroreflex Activation Therapy which in turn triggers an autonomic response to the heart. The majority of revenue is derived from the USA market.
56GF Score

Get the complete analysis for CVRX

5-Year Yield-on-Cost % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$5.74
Price
$11.27
GF Value